Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer
Open Access
- 1 May 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (5) , e2314748
Abstract
Approximately 30% to 50% of patients with prostate cancer develop a biochemical relapse or prostate-specific antigen (PSA) persistence within the first 5 years after primary radical prostatectomy.1,2 Current international guidelines3 recommend early salvage radiotherapy (sRT) directed to the prostate bed with or without androgen deprivation therapy (ADT) in this disease setting; predictive nomograms are widely used to provide individualized estimates of biochemical relapse after sRT.4 However, prostate-specific membrane antigen positron-emission tomography (PSMA-PET) is increasingly used for staging patients with biochemical relapse or PSA persistence after radical prostatectomy,5 which affects the treatment decision process prior to delivery of sRT.6,7Keywords
This publication has 20 references indexed in Scilit:
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysisEuropean Urology, 2020
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate CancerJAMA Oncology, 2019
- Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective AnalysisJournal of Nuclear Medicine, 2018
- Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate CancerJAMA, 2018
- Dose Response and Fractionation Sensitivity of Prostate Cancer After External Beam Radiation Therapy: A Meta-analysis of Randomized TrialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Treatment Outcomes from 68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PETJournal of Nuclear Medicine, 2017
- Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical ProstatectomyJournal of Clinical Oncology, 2016
- Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate CancerEuropean Urology, 2015
- Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 TrialEuropean Urology, 2014
- Principal components analysis (PCA)Computers & Geosciences, 1993